Search
for
Sort by
Research 541–570 of 1000+
- Role of low dose oral minoxidil in the treatment of hair loss: A review
- Low‐Dose Oral Versus Topical Minoxidil in Androgenetic Alopecia: A Randomized, Double‐Blind, Double‐Dummy Controlled Trial
- CARDIOVASCULAR SAFETY OF LOW-DOSE ORAL MINOXIDIL FOR ANDROGENETIC ALOPECIA IN PATIENTS WITH HYPERTENSION OR ARRHYTHMIAS
- Low-dose oral minoxidil for pediatric and young-adult hair loss: a cross-sectional survey of satisfaction and perceived benefit
- Low Dose Oral Minoxidil in Androgenetic Alopecia
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Low-Dose Oral Minoxidil Improves Hairline and Eyebrow Coverage in Frontal Fibrosing Alopecia: A Prospective Study
- Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process
- Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process
- Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern hair loss in hair transplant patients using a modified Delphi process
- Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss.
- Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern Hair loss in Hair transplant patients using a modified delphi process
- No Association between Patient Demographics and Adverse Effects of Low-Dose Oral Minoxidil in a Retrospective Cohort study of Nonscarring Alopecia Patients
- Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss
- Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss
- Low-Dose Oral Minoxidil as Treatment for COVID-19–Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients
- Real-World Quantification of Treatment Response to Low-Dose Oral Minoxidil in Non-Scarring Alopecia
- Treatment of Short Anagen Syndrome With Low‐Dose Oral Minoxidil
- EFFICACY AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN THE TREATMENT OF ANDROGENETIC ALOPECIA – A LITERATURE REVIEW
- 61131 Impact of Low-Dose Oral Minoxidil on Blood Pressure in Androgenetic Alopecia Patients Concomitantly Taking Antihypertensive Medications: A Multi-Center Cohort Study
- 62335 Low Dose Oral Minoxidil vs Topical Minoxidil for Androgenetic Alopecia: Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Low-Dose Oral Minoxidil During Chemotherapy: A Review of the Mechanism and Current Evidence
- LB1101 Evaluating the cardiovascular safety of low-dose oral minoxidil in patients with non-scarring alopecia: A retrospective cohort study
- BH04 Growing interest: a survey of low-dose oral minoxidil prescribing for hair loss
- Xerostomia as a rare adverse effect of low-dose oral minoxidil: a case report with recurrence after re-challenge
- The Requirement to Monitor Low-dose Oral Minoxidil in the Management of Hair Loss
- Low-dose oral minoxidil for androgenetic alopecia is not associated with blood pressure changes in patients also taking other antihypertensive medications: A multi-center cohort study using TriNetX
- Characterization and Management of Adverse Events of Low-Dose Oral Minoxidil Treatment for Alopecia: A Narrative Review
- ASSESSING THE EFFECTIVENESS AND SAFETY OF LOW-DOSE ORAL MINOXIDIL IN ANDROGENETIC ALOPECIA: A 24-WEEK CLINICAL STUDY
- Analysing efficacy of low-dose oral minoxidil, topical minoxidil, and platelet-rich plasma with topical minoxidil combination in patients with androgenetic alopecia: a randomized controlled observer blinded trial